Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00426712
Status:
COMPLETED
Last Update Posted:
2019-03-20
First Post:
2007-01-23
Brief Title:
Safety of HEPLISAV Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients
Sponsor:
Dynavax Technologies Corporation
Organization:
Dynavax Technologies Corporation
Organization Data
Organization:
Dynavax Technologies Corporation
Class:
INDUSTRY
Study ID:
DV2-HBV-09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dynavax Technologies Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None